Cargando…
Correlation between gut microbiome and cognitive impairment in patients undergoing peritoneal dialysis
BACKGROUND: Growing evidence has demonstrated that patients undergoing peritoneal dialysis (PD) are more likely to experience cognitive impairment than patients with non-dialysis end-stage renal disease (ESRD); however, the underlying mechanisms remain unclear. This study aimed to identify the role...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696889/ http://dx.doi.org/10.1186/s12882-023-03410-z |
_version_ | 1785154668572180480 |
---|---|
author | Wang, Jingjing Wu, Siyang Zhang, Jin Li, Yuanyuan Wu, Yonggui Qi, Xiangming |
author_facet | Wang, Jingjing Wu, Siyang Zhang, Jin Li, Yuanyuan Wu, Yonggui Qi, Xiangming |
author_sort | Wang, Jingjing |
collection | PubMed |
description | BACKGROUND: Growing evidence has demonstrated that patients undergoing peritoneal dialysis (PD) are more likely to experience cognitive impairment than patients with non-dialysis end-stage renal disease (ESRD); however, the underlying mechanisms remain unclear. This study aimed to identify the role and predictive significance of gut microbiome alterations in PD-associated cognitive impairment. METHODS: A total of 29 non-dialysis ESRD patients and 28 PD patients were enrolled in this study and divided into subgroups according to the Montreal Cognitive Assessment (MoCA). Faecal samples were analyzed using 16 S rRNA. Mini-Mental State Examination (MMSE) and MoCA scores were used to assess the degree of cognitive impairment in patients. RESULTS: The 16 S rRNA analysis demonstrated differences in gut microbiome abundance and structure between PD and non-dialysis ESRD patients and between PD patients with cognitive impairment (PCI) and PD patients with normal cognition (PNCI). At family and genus levels, Prevotellaceae exhibited the greatest structure difference, while Lactobacillus exhibited the greatest abundance difference between PCI and PNCI. Altered microbiota abundance significantly correlated with cognitive function and serum indicators in PD. In addition, different modules related to fatty acid, lipid, pantothenate, and coenzyme A biosynthesis, and tyrosine and tryptophan metabolism were inferred from 16 S rRNA data between PCI and PNCI. Both groups could be distinguished using models based on the abundance of Lactobacillaceae (Area under curve [AUC] = 0.83), Actinomycetaceae (AUC = 0.798), and Prevotellaceae (AUC = 0.778) families and Lactobacillus (AUC = 0.848) and Actinomyces (AUC = 0.798) genera. CONCLUSION: Gut microbiome evaluation could aid early cognitive impairment diagnosis in patients undergoing PD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-023-03410-z. |
format | Online Article Text |
id | pubmed-10696889 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-106968892023-12-06 Correlation between gut microbiome and cognitive impairment in patients undergoing peritoneal dialysis Wang, Jingjing Wu, Siyang Zhang, Jin Li, Yuanyuan Wu, Yonggui Qi, Xiangming BMC Nephrol Research BACKGROUND: Growing evidence has demonstrated that patients undergoing peritoneal dialysis (PD) are more likely to experience cognitive impairment than patients with non-dialysis end-stage renal disease (ESRD); however, the underlying mechanisms remain unclear. This study aimed to identify the role and predictive significance of gut microbiome alterations in PD-associated cognitive impairment. METHODS: A total of 29 non-dialysis ESRD patients and 28 PD patients were enrolled in this study and divided into subgroups according to the Montreal Cognitive Assessment (MoCA). Faecal samples were analyzed using 16 S rRNA. Mini-Mental State Examination (MMSE) and MoCA scores were used to assess the degree of cognitive impairment in patients. RESULTS: The 16 S rRNA analysis demonstrated differences in gut microbiome abundance and structure between PD and non-dialysis ESRD patients and between PD patients with cognitive impairment (PCI) and PD patients with normal cognition (PNCI). At family and genus levels, Prevotellaceae exhibited the greatest structure difference, while Lactobacillus exhibited the greatest abundance difference between PCI and PNCI. Altered microbiota abundance significantly correlated with cognitive function and serum indicators in PD. In addition, different modules related to fatty acid, lipid, pantothenate, and coenzyme A biosynthesis, and tyrosine and tryptophan metabolism were inferred from 16 S rRNA data between PCI and PNCI. Both groups could be distinguished using models based on the abundance of Lactobacillaceae (Area under curve [AUC] = 0.83), Actinomycetaceae (AUC = 0.798), and Prevotellaceae (AUC = 0.778) families and Lactobacillus (AUC = 0.848) and Actinomyces (AUC = 0.798) genera. CONCLUSION: Gut microbiome evaluation could aid early cognitive impairment diagnosis in patients undergoing PD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-023-03410-z. BioMed Central 2023-12-05 /pmc/articles/PMC10696889/ http://dx.doi.org/10.1186/s12882-023-03410-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Wang, Jingjing Wu, Siyang Zhang, Jin Li, Yuanyuan Wu, Yonggui Qi, Xiangming Correlation between gut microbiome and cognitive impairment in patients undergoing peritoneal dialysis |
title | Correlation between gut microbiome and cognitive impairment in patients undergoing peritoneal dialysis |
title_full | Correlation between gut microbiome and cognitive impairment in patients undergoing peritoneal dialysis |
title_fullStr | Correlation between gut microbiome and cognitive impairment in patients undergoing peritoneal dialysis |
title_full_unstemmed | Correlation between gut microbiome and cognitive impairment in patients undergoing peritoneal dialysis |
title_short | Correlation between gut microbiome and cognitive impairment in patients undergoing peritoneal dialysis |
title_sort | correlation between gut microbiome and cognitive impairment in patients undergoing peritoneal dialysis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696889/ http://dx.doi.org/10.1186/s12882-023-03410-z |
work_keys_str_mv | AT wangjingjing correlationbetweengutmicrobiomeandcognitiveimpairmentinpatientsundergoingperitonealdialysis AT wusiyang correlationbetweengutmicrobiomeandcognitiveimpairmentinpatientsundergoingperitonealdialysis AT zhangjin correlationbetweengutmicrobiomeandcognitiveimpairmentinpatientsundergoingperitonealdialysis AT liyuanyuan correlationbetweengutmicrobiomeandcognitiveimpairmentinpatientsundergoingperitonealdialysis AT wuyonggui correlationbetweengutmicrobiomeandcognitiveimpairmentinpatientsundergoingperitonealdialysis AT qixiangming correlationbetweengutmicrobiomeandcognitiveimpairmentinpatientsundergoingperitonealdialysis |